If C. abortus is identified in a flock, a veterinary-devised plan combining vaccination with Cevac Chlamydia, biosecurity and only purchasing stock from accredited flocks will assist disease control and eventual eradication.

Assure Ewe Launch Offers Investigative Support For Sheep Vets

9 years ago
2378 views

Posted
3rd May, 2017 16h09

Assure Ewe launch offers investigative support for sheep vets

Industry estimates that 12 million accessible breeding ewes (91%) are not vaccinated against enzootic abortion in the UK ought to concern all practitioners with sheep clients. Any flock with an abortion rate of over 2% could well be suffering from this disease, at a cost of £85 per aborted ewe; losses producers can ill-afford to ignore.

Ceva Animal Health’s newly launched Assure Ewe subsidised testing scheme can assist practitioners identify the cause on-farm in an easily-accessible way.

“Abortion remains one of the most significant reasons for loss in sheep flocks and an abortion storm can lead to crippling results on farm,” explains Ceva’s Stephenie Clarke.  “Enzootic abortion caused by C. abortus remains the main cause of ovine abortion in the UK1 and once in a flock, takes time to control as exposed ewes can become latently infected.”

Assure Ewe is a subsidised blood testing scheme open to all flocks with 50 or more breeding ewes; in contrast to other schemes, evidence of an abortion does not need to have taken place.

Blood samples should be collected from six ewes, with full farm and vet details also supplied.  Upon results, Ceva will share information with the participating vet to discuss with the farmer.

“Assure Ewe is a very user friendly, simple scheme that will help facilitate conversations between vets and farmers while, at the same time, providing useful testing information to vets,” Dr Clarke adds. “Ceva encourages evidence based veterinary decisions, and this is just one example of such an initiative.”

If C. abortus is identified in a flock, a veterinary-devised plan combining vaccination with Cevac® Chlamydia, biosecurity and only purchasing stock from accredited flocks will assist disease control and eventual eradication.

Contact your Ceva territory manager for further information on the scheme.

ENDS

1 Nadis Abortion in Ewes editorial information www.nadis.org.uk

JPEG of 50 dose and 20 dose packs accompanies this release.

For further press information, please contact: Charlotte Grime at MG Communications on +44 (0)1488 657722/+44 (0)7787 551877 or email [email protected]

Use medicines responsibly

Active ingredient: live attenuated 1B strain of Chlamydophila abortus vaccine. Legal category POM-V. Cevac® Chlamydia is licensed for use with toxoplasmosis vaccines and can be applied on the same day at separate injection sites.

Further information is available in the SPC or from Ceva Animal Health Ltd., Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB Tel: 01494 781510 www.ceva.co.uk               

About Ceva:

Ceva Santé Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for ruminants, pets, swine and poultry. Visit: www.ceva.com 

More from

• Vetsure Named Business of the Year at 2025 SME National Business Awards
• Home of hope for Romania's dogs: The pioneering shelter doing things differently
• Pioneering new locum platform transforming veterinary landscape
• Key Stakeholders unite to advance helmet design for equine veterinary professionals
• Hallmarq hails transformational equine imaging technology